FDA WARNING_LETTER - thefinesteliquid.com - March 18, 2025

On March 13, 2025, the FDA's Center for Tobacco Products issued a Warning Letter to the entity operating https://www.thefinesteliquid.com, identifying e-liquid products offered for sale in the U.S. as tobacco products under section 201(rr) of the FD&C Act. This includes products containing nicotine from any source, following the Consolidated Appropriations Act, 2022.

The FDA determined that "Finest - Fruit Edition – Apple Pearadise" and "Finest - Signature Edition – Tiramisu Custard" are "new tobacco products" that were not commercially marketed in the U.S. as of February 15, 2007. These products lack the required FDA marketing authorization order under section 910(c)(1)(A)(i) of the FD&C Act, or an exemption. Consequently, they are deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act due to the absence of required premarket authorization or notice.

The letter mandates a written response within 15 working days detailing actions taken to address violations, including discontinuation of violative sales and a plan for future compliance. Failure to comply may result in regulatory actions such as civil money penalties, seizure, and/or injunction. The letter also notes that